-
1 month ago | 
cellandgene.com | Ben Baumann
By Ben Baumann
OpenClinica Recruit is transforming patient recruitment for academic research organizations (AROs) by delivering targeted, effective solutions that drive enrollment success. With a proven track record of enrolling over 50,000 participants across 1,200+ studies and 250+ therapeutic areas, OpenClinica's platform is HIPAA-compliant and university-approved, ensuring seamless, efficient, and compliant recruitment.
-
Jan 22, 2025 | 
cellandgene.com | Ben Baumann
By Ben Baumann
eConsent is transforming clinical research sites by addressing key pain points and streamlining processes for overburdened staff. During a webinar hosted by OpenClinica, experts discussed challenges such as overworked site staff, inefficient patient recruitment, and labor-intensive data collection. They emphasized the role of eConsent in simplifying multi-site studies through centralized and standardized processes, reducing the manual workload and ensuring compliance.
-
Jan 22, 2025 | 
clinicalleader.com | Ben Baumann
By Ben Baumann
Traditionally avoided due to complexity, mid-study migrations are becoming essential as trials increasingly extend beyond initial EDC system capabilities or organizational needs change. OpenClinica has developed and proven a robust process for seamless mid-study data migrations, ensuring minimal disruptions and complete data integrity. Key components of the process include rigorous testing and validation, data mapping, team coordination, and comprehensive training.
-
Dec 2, 2024 | 
clinicalleader.com | Ben Baumann |Darshan Dave |Opportunities White Paper
What Can We Learn From A Highly Diverse Observational Study Of 17,000+ Patients? CMO William Audeh, MD, details Agendia’s diverse, high-enrolling trial and how sponsor companies of investigational trials might benefit from its experiences. Four Ways To Strengthen Patient Engagement In Clinical TrialsInterest in clinical trials is rising, with more people willing to participate. Here are four ways to strengthen patient engagement and enhance their experience in clinical research.
-
Nov 5, 2024 | 
clinicalleader.com | Dan Schell |Ben Baumann |Colin Weller
Webinar: Unleash the Power of IQVIA Complete ConsentThe eConsent market is evolving, focusing on improving patient experiences, streamlining clinical trial processes, and global expansion. Staying informed on industry developments is crucial.
-
Oct 25, 2024 | 
cellandgene.com | Jennifer Chain |Ben Baumann |Aman Khera
Advanced cell-based therapies are impossible without high-quality leukopaks from high-quality donors. Improve Bioprocess Freezing Outcomes With Analytics And Testing ServicesWhile AI is an exciting area for the biopharmaceutical sector, other shorter-term and more tangible things can be done to get life-saving medicines to market faster.
-
Sep 30, 2024 | 
clinicalleader.com | Ben Baumann
Article
| October 1, 2024
By Ben Baumann
OpenClinica's Insight™ reporting module has been lauded for its transformative impact on clinical trial management, particularly in site performance monitoring and patient data analysis. Insight™ features comprehensive dashboards and tools that allow sponsors to visualize and analyze clinical data.
-
Jul 26, 2024 | 
clinicalleader.com | Thierry Escudier |Aditya Tyagi |Pistoia Alliance |Ben Baumann
Patient recruitment and retention is a multi-faceted, critical component of clinical trial success. Diversity, timeliness, enrollment, reimbursement, logistics, engagement – where do you start? On August 7th, hear from industry-leading suppliers ready to answer that question – and help solve your specific recruitment and retention challenges. The Clinical Leader Solutions Expo brings you its latest virtual event to help facilitate partnerships that bring life-saving therapies to patients.
-
Jul 18, 2024 | 
cellandgene.com | Ben Baumann |Daniel Schaefer |Daniel Schäefer |Laura N. Kuster
With a strong focus on quality and patient-centricity, GC Cell provides seamless solutions from process development to clinical material and commercial production. We have a proven track record and are involved in cutting-edge research and development projects. GC Cell fully understands the unique challenges around Cell & Gene Therapy development and manufacturing. Explore our end-to-end, customer-centric CDMO services that are helping to bring more breakthrough treatments to patients.
-
Jul 18, 2024 | cellandgene.com | Ben Baumann |Daniel Schaefer |Daniel Schäefer |Laura N. Kuster
With a strong focus on quality and patient-centricity, GC Cell provides seamless solutions from process development to clinical material and commercial production. We have a proven track record and are involved in cutting-edge research and development projects. GC Cell fully understands the unique challenges around Cell & Gene Therapy development and manufacturing. Explore our end-to-end, customer-centric CDMO services that are helping to bring more breakthrough treatments to patients.
